Effects of ebselen versus nimodipine on cerebral vasospasm subsequent to experimental subarachnoid hemorrhage in rats

Journal of Clinical Neuroscience

Volumn 17, Issue 5, 2010, Pages 608-611

  Gul, Sanser ^a   Bahadir, Burak ^a   Hanci, Volkan ^a   Acikgoz, Serefden ^a   Bektas, Sibel ^a   Ugurbas, Ebru ^a   Ankarali, Handan ^a   Kalayci, Murat ^a   Acikgoz, Bektaş ^a  

^a ZONGULDAK KARAELMAS UNIVERSITY   (Turkey)

Author keywords

Cerebral vasospasm; Ebselen; Glutathione peroxidase; Neuroprotection; Nimodipine; Subarachnoid hemorrhage

Indexed keywords

EBSELEN; MALONALDEHYDE; NIMODIPINE; SODIUM CHLORIDE; SUPEROXIDE DISMUTASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BASILAR ARTERY; BLOOD AUTOTRANSFUSION; BLOOD SAMPLING; BRAIN; BRAIN VASOSPASM; CISTERNA MAGNA; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVITY; FEMALE; HISTOPATHOLOGY; LIPID PEROXIDATION; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; RAT; SUBARACHNOID HEMORRHAGE; WISTAR RAT;

ANALYSIS OF VARIANCE; ANIMALS; ANTIOXIDANTS; AZOLES; BRAIN; DRUG ADMINISTRATION SCHEDULE; FEMALE; INJECTIONS, INTRAVENTRICULAR; MALONDIALDEHYDE; NIMODIPINE; ORGANOSELENIUM COMPOUNDS; OXIDATIVE STRESS; RATS; RATS, WISTAR; SUBARACHNOID HEMORRHAGE; SUPEROXIDE DISMUTASE; VASODILATOR AGENTS; VASOSPASM, INTRACRANIAL;

EID: 77950299570     PISSN: 09675868     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jocn.2009.07.115     Document Type: Article

References (32)

1. Yan J., Chen C., Lei J., et al. 2-Methoxyestradiol reduces cerebral vasospasm after 48 hours of experimental subarachnoid hemorrhage in rats. Exp Neurol 202 (2006) 348-356
2. Barry K.J., Gogjian M.A., and Stein B.M. Small animal model for investigation of subarachnoid hemorrhage and cerebral vasospasm. Stroke 10 (1979) 538-542
3. Dawson D.A., Masayasu H., Graham D.I., et al. The neuroprotective efficacy of ebselen (a glutathione peroxidase mimic) on brain damage induced by transient focal cerebral ischemia in the rat. Neurosci Lett 185 (1995) 65-69
4. Handa Y., Kaneko M., Takeuchi H., et al. Effect of an antioxidant, ebselen, on development of chronic cerebral vasospasm after subarachnoid hemorrhage in primates. Surg Neurol 53 (2000) 323-329
5. Imai H., Mayasu H., Dewar D., et al. Ebselen protects both gray and white matter in a rodent model of focal cerebral ischemia. Stroke 32 (2001) 2149-2154
6. Knollema S., Elting J.W., Dijkhuizen R.M., et al. Ebselen (PZ-51) protects the caudate putamen against hypoxia/ischemia induced neuronal damage. Neurosci Res Commun 19 (1996) 47-56
7. Porciúncula L.O., Rocha J.B., Cimarosti H., et al. Neuroprotective effect of ebselen on rat hippocampal slices submitted to oxygen-glucose deprivation: correlation with immunocontent of inducible nitric oxide synthase. Neurosci Lett 346 (2003) 101-104
8. Saito I., Asano T., Sano K., et al. Neuroprotective effect of an antioxidant, ebselen, in patients with delayed neurological deficits after aneurysmal subarachnoid hemorrhage. Neurosurgery 42 (1998) 269-277 [Discussion 277-278]
9. Schewe T. Molecular actions of ebselen: an anti-inflammatory antioxidant. Gen Pharmacol 26 (1995) 1153-1169
10. Takasago T., Peters E.E., Graham D.I., et al. Neuroprotective efficacy of ebselen, an anti-oxidant with anti-inflammatory actions, in a rodent model of permanent middle cerebral artery occlusion. Br J Clin Pharmacol 122 (1997) 1251-1256
11. Yamaguchi T., Sano K., Takakura K., et al. Ebselen in acute ischemic stroke. Stroke 29 (1998) 12-17
12. Bederson J.B., Germano I.M., and Guarino L. Cortical blood flow and cerebral perfusion pressure in a new noncraniotomy model of subarachnoid hemorrhage in the rat. Stroke 26 (1995) 1086-1092
13. Ohkawa H., Ohishi N., and Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 95 (1979) 351-358
14. Sun Y., Larry W.O., and Li Y. A simple method for clinical assay of superoxide dismutase. Clin Chem 34 (1988) 497-500
15. Dumont A.S., Dumont R.J., Chow M.M., et al. Cerebral vasospasm after subarachnoid hemorrhage: putative role of inflammation. Neurosurgery 53 (2003) 123-133
16. Sonobe M., and Suzuki J. Vasospasmogenic substrates produced following subarachnoid hemorrhage, and its fate. Acta Neurochir 44 (1978) 97-106
17. Macdonald R.L., Weir B.K., Runzer T.D., et al. Malondialdehyde, glutathione peroxidase, and superoxide dismutase in cerebrospinal fluid during cerebral vasospasm in monkeys. Can J Neurol Sci 19 (1992) 326-332
18. Kamii H., Kato I., Kinouchi H., et al. Amelioration of vasospasm after subarachnoid hemorrhage in transgenic mice overexpressing CuZn-superoxide dismutase. Stroke 30 (1999) 867-872
19. McGirt M.J., Para A., Sheng H., et al. Attenuation of cerebral vasospasm after subarachnoid hemorrhage in mice overexpressing extracellular superoxide dismutase. Stroke 33 (2002) 2317-2323
20. Sakaki S., Kuwabara H., and Ohta S. Biological defense mechanism in the pathogenesis of prolonged cerebral vasospasm in the patients with ruptured intracranial aneurysms. Stroke 17 (1986) 196-202
21. Karaoglan A., Akdemir O., Barut S., et al. The effects of resveratrol on vasospasm after experimental subarachnoid hemorrhage in rats. Surg Neurol 70 (2007) 337-343
22. Lanzino G., Kassell N.F., Dorch N.W., et al. Double-blind, randomized, vehicle-controlled study of high dose tirilazad mesylate in women with aneurysmal subarachnoid hemorrhage. Part I. A cooperative study in North America. J Neurosurg 90 (1999) 1011-1017
23. Zuccarello M., Boccaletti R., and Romano A. Endothelin b receptor antagonists attenuate subarachnoid hemorrhage-induced cerebral vasospasm. Stroke 29 (1998) 1924-1929
24. Macdonald R.L. Management of cerebral vasospasm. Neurosurg Rev 29 (2006) 179-193
25. Barker II F.G., and Ogilvy C.S. Efficacy of prophylactic nimodipine for delayed ischemic deficit after subarachnoid hemorrhage: a metaanalysis. J Neurosurg 84 (1996) 405-414
26. Rinkel G.J., Feigin V.L., Algra A., et al. Calcium antagonists for aneurysmal subarachnoid haemorrhage. Cochrane Database Syst Rev 25 (2005) CD000277
27. Lapchak P.A., and Zivin J.A. Ebselen, a seleno-organic antioxidant, is neuroprotective after embolic stroke in rabbits. Stroke 34 (2003) 2013-2025
28. 3H] glutamate uptake by synaptic vesicles from rat brain. Brain Res 1027 (2004) 192-195
29. Salom J.B., Perez-Asensio F.J., Burguete M.C., et al. Single-dose ebselen does not afford sustained neuroprotection to rats subjected to severe focal cerebral ischemia. Eur J Clin Pharmacol 495 (2004) 55-62
30. Namura S., Nagata I., Takami S., et al. Ebselen reduces cytochrome c release from mitochondria and subsequent DNA fragmentation after transient focal cerebral ischemia in mice. Stroke 32 (2001) 1906-1911
31. Gladilin S., Bidmon H.J., Divanach A., et al. Ebselen lowers plasma interleukin-6 levels and glial heme oxygenase-1 expression after focal photothrombotic brain ischemia. Arch Biochem Biophys 380 (2000) 237-242
32. Ogawa A., Yoshimoto T., Kikuchi H., et al. Ebselen in acute middle cerebral artery occlusion: a placebo-controlled, double-blind clinical trial. Cerebrovasc Dis 9 (1999) 112-118